Key Highlights
- EMD Serono relocates U.S. Healthcare headquarters to Boston’s Seaport district, aiming to integrate into the healthcare innovation hub.
- Plans to launch new products every 1.5 years, starting with two U.S. launches in 2025, in Neurology & Immunology, Oncology, and Fertility.
- Boston Mayor Michelle Wu welcomes EMD Serono, emphasizing Boston’s status as a global healthcare leader.
Source: Business Wire
Notable Quotes
- “The U.S. market is critical to our continued success as a global specialty innovator,” – Chris Round, President at EMD Serono
- “Boston continues to be the leading global healthcare hub, and we are excited to welcome EMD Serono employees to our community,” -Michelle Wu, Mayor at Boston
SoH's Take
EMD Serono’s decision to move its U.S. Healthcare headquarters to Boston’s Seaport district represents a significant strategic shift, positioning the company at the heart of a leading global healthcare innovation hub. This move is not just about changing locations; it’s a statement of intent, showcasing EMD Serono’s commitment to being at the forefront of healthcare innovation.
